Table 1. Clinical and epidemiologic parameters in COVID-19 positive ICU versus non-ICU and death versus recovered cases.
COVID-19, coronavirus disease 2019; ICU, intensive care unit
| Variable | Category | ICU | Non-ICU | Test of significance (p-value) | Death | Recovered | Test of significance (p-value) |
| Age | 1-15 years | 3 (37.5%) | 5 (62.5%) | 0.003 | 1 (12.5%) | 7 (87.5%) | 0.016 |
| 16-30 years | 1 (5.3%) | 18 (94.7%) | 0 (0%) | 19 (100%) | |||
| 31- 45 years | 15 (33.3%) | 30 (66.7%) | 5 (11.1%) | 40 (88.9%) | |||
| 46- 60 years | 32 (34.0%) | 62 (66.0%) | 15 (16.0%) | 79 (84.0%) | |||
| 61- 75 years | 39 (53.4%) | 34 (46.6%) | 20 (26.4%) | 53 (73.6%) | |||
| >76 years | 7 (53.8%) | 6 (46.2%) | 5 (38.5%) | 8 (61.5%) | |||
| Gender | Male | 81 (45.3%) | 98 (54.7%) | 0.001 | 37(20.7%) | 142 (79.3%) | 0.120 |
| Female | 16 (21.9%) | 57 (78.1%) | 9 (12.3%) | 64 (87.7%) | |||
| Residence | Urban | 50 (40.7%) | 73 (59.3%) | 0.492 | 23(18.7%) | 100 (81.3%) | 0.858 |
| Rural | 47 (36.4%) | 82 (63.6%) | 23 (17.8%) | 106 (82.2%) | |||
| Travel history | Yes | 96 (38.6%) | 153 (61.4%) | 0.853 | 1(33.3%) | 2 (66.7%) | 0.496 |
| No | 1 (33.3%) | 2 (66.7%) | 45 (18.1%) | 204 (81.9%) | |||
| Contact history | Yes | 92(39.0%) | 144 (61.0%) | 0.538 | 3(18.8%) | 13 (81.2%) | 0.958 |
| No | 5 (31.2%) | 11 (68.8%) | 43 (18.2%) | 193 (81.8%) | |||
| Fever | Yes | 73 (62.93%) | 43 (37.07%) | 0.600 | 35 (30.17%) | 81 (69.83%) | 0.650 |
| No | 24 (35.5%) | 112 (60.5%) | 11 (8.1%) | 125 (91.9%) | |||
| Headache | Yes | 4 (50.0%) | 4 (50.0%) | 0.497 | 2 (25.0%) | 6 (75.0%) | 0.497 |
| No | 93 (38.1%) | 151 (61.9%) | 44 (18.0%) | 200 (82.0%) | |||
| Dyspnea | Yes | 80 (52.3%) | 73 (47.7%) | <0.001 | 34 (22.2%) | 119 (77.8%) | 0.616 |
| No | 17 (17.2%) | 82 (82.8%) | 12 (12.1%) | 87 (87.9%) | |||
| Loss of taste | Yes | 2 (40.0%) | 3 (60.0%) | 0.930 | 0 (0%) | 5 (100.0%) | 0.566 |
| No | 95 (38.5%) | 152 (61.5%) | 46 (18.6%) | 201 (81.4%) | |||
| Diabetes | Yes | 39 (45.3%) | 47 (54.7%) | 0.107 | 21 (24.4%) | 65 (75.6%) | 0.068 |
| No | 58 (34.9%) | 108 (65.1%) | 25 (15.1%) | 141 (84.9%) | |||
| Hypertension | Yes | 43 (43.9%) | 55 (56.1%) | 0.161 | 21 (21.4%) | 77 (78.6%) | 0.298 |
| No | 54 (35.1%) | 100 (64.9%) | 25 (16.2%) | 129 (83.8%) | |||
| Cardiovascular disease | Yes | 8 (40.0%) | 12 (60.0%) | 0.885 | 3 (15.0%) | 17 (85.0%) | 0.695 |
| No | 89 (38.4%) | 143 (61.6%) | 43 (18.5%) | 189 (81.6%) | |||
| Pulmonary disease | Yes | 3 (20.0%) | 12 (80.0%) | 0.129 | 2 (13.3%) | 13 (86.7%) | 0.611 |
| No | 94 (39.7%) | 143 (60.3%) | 44 (18.6%) | 193 (81.4%) | |||
| Liver disease | Yes | 6 (66.7%) | 3 (33.3%) | 0.077 | 4 (44.4%) | 5 (55.6%) | 0.038 |
| No | 91 (37.4%) | 152 (62.6%) | 42 (17.3%) | 201 (82.7%) | |||
| Chronic renal disease | Yes | 7 (41.18%) | 10 (58.82%) | 0.814 | 6 (35.3%) | 11 (64.7%) | 0.060 |
| No | 90 (38.3%) | 145 (61.7%) | 40 (20.5%) | 195 (79.5%) | |||
| Malignancy | Yes | 2 (33.3%) | 4 (66.7%) | 0.793 | 2 (33.3%) | 4 (66.7%) | 0.333 |
| No | 95 (38.6%) | 151 (61.4%) | 44 (17.9%) | 202 (82.1%) |